These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 17251808)

  • 1. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye.
    Khanal S; Tomlinson A; Pearce EI; Simmons PA
    Cornea; 2007 Feb; 26(2):175-81. PubMed ID: 17251808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of artificial tears in the management of evaporative dry eye.
    McCann LC; Tomlinson A; Pearce EI; Papa V
    Cornea; 2012 Jan; 31(1):1-5. PubMed ID: 21968605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of castor oil emulsion eyedrops on tear film composition and stability.
    Maïssa C; Guillon M; Simmons P; Vehige J
    Cont Lens Anterior Eye; 2010 Apr; 33(2):76-82. PubMed ID: 19963428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential changes of lipid tear film after the instillation of a single drop of a new emulsion eye drop in dry eye patients.
    Di Pascuale MA; Goto E; Tseng SC
    Ophthalmology; 2004 Apr; 111(4):783-91. PubMed ID: 15051213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness.
    Scaffidi RC; Korb DR
    Eye Contact Lens; 2007 Jan; 33(1):38-44. PubMed ID: 17224677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of humidity variations in a controlled environment chamber on tear evaporation after dry eye therapy.
    Madden LC; Tomlinson A; Simmons PA
    Eye Contact Lens; 2013 Mar; 39(2):169-74. PubMed ID: 23411993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new lipid tear substitute in a mouse model of dry eye.
    Scifo C; Barabino S; De Pasquale G; Blanco AR; Mazzone MG; Rolando M
    Cornea; 2010 Jul; 29(7):802-6. PubMed ID: 20489574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in corneal sensitivity and tear physiology after phacoemulsification.
    Khanal S; Tomlinson A; Esakowitz L; Bhatt P; Jones D; Nabili S; Mukerji S
    Ophthalmic Physiol Opt; 2008 Mar; 28(2):127-34. PubMed ID: 18339043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients.
    Hom MM
    Eye Contact Lens; 2006 Mar; 32(2):109-11. PubMed ID: 16538135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
    Barber LD; Pflugfelder SC; Tauber J; Foulks GN
    Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye.
    Nichols JJ; Sinnott LT
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1319-28. PubMed ID: 16565363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical performance of a mid-viscosity artificial tear for dry eye treatment.
    Simmons PA; Vehige JG
    Cornea; 2007 Apr; 26(3):294-302. PubMed ID: 17413956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM; McGwin G; Liu B; Owsley C; Rosenstiel C
    Eye Contact Lens; 2008 Jan; 34(1):43-5. PubMed ID: 18180683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production.
    Pflugfelder SC; De Paiva CS; Villarreal AL; Stern ME
    Cornea; 2008 Jan; 27(1):64-9. PubMed ID: 18245969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of treatment of the dry eye syndrome due to disturbances of the tear film lipid layer with lipid-containing tear substitutes].
    Dausch D; Lee S; Dausch S; Kim JC; Schwert G; Michelson W
    Klin Monbl Augenheilkd; 2006 Dec; 223(12):974-83. PubMed ID: 17199193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artificial tears on tear stress test.
    Khanal S; Simmons PA; Pearce EI; Day M; Tomlinson A
    Optom Vis Sci; 2008 Aug; 85(8):732-9. PubMed ID: 18677237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
    Lee S; Dausch S; Maierhofer G; Dausch D
    Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful tear lipid layer treatment for refractory dry eye in office workers by low-dose lipid application on the full-length eyelid margin.
    Goto E; Dogru M; Fukagawa K; Uchino M; Matsumoto Y; Saiki M; Tsubota K
    Am J Ophthalmol; 2006 Aug; 142(2):264-70. PubMed ID: 16876507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot, prospective, randomized, double-masked, placebo-controlled clinical trial of an omega-3 supplement for dry eye.
    Wojtowicz JC; Butovich I; Uchiyama E; Aronowicz J; Agee S; McCulley JP
    Cornea; 2011 Mar; 30(3):308-14. PubMed ID: 21045648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.